Friday, 04 December 2009 06:49
Shares of SIGA Technologies (Nasdaq:SIGA), traded down by over three percent on Thursday in what I consider to be more of a 'tree shake' than any kind of sell-off.
Investors are still expecting an announcement any day regarding a possible BARDA small pox contract, and impatient investors are sure to get antsy with every day that goes by without a contract announcement. It's those investors that are targeted with a 'tree shake', when the share price of a stock is dropped on relatively low volume in order to 'shake shares' from those with weak stomachs who sell at the slightest sign of trouble.
The tree shake also takes out stop loss orders and, more often than not, in a tree shake - once the stop losses are eaten up the stock will rise again.
In the case of Thursday's decline, the stock was dropped late day on a series of 100 share orders that, in my opinion, mean little to the big picture and potential of the SIGA stock, especially with a BARDA announcement possibly imminent.
If bad news regarding the contract were leaked, then I think that we would have seen much more of a sell-off than we saw yesterday; volume came in below the three month average.
It's status-quo for SIGA's short term future, a waiting game until we hear from BARDA.
As a bonus, please be aware that sources are telling BioMedReports that the company may be getting a very nice grant from a different government entity in the coming weeks. It looks like it may be a very nice holiday season for SIGA and their investors.
In my opinion, news is very close.
Disclosure: Long SIGA call options.
"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.
Add this page to your favorite Social Bookmarking websites